+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
BALPHARMA
₹87.05 -1.19 (-1.35%)
45.08% Gain from 52W Low

14 Aug, 2026 3:54 PM (IST)

Bal Pharma live price: ₹87.05. It opened at ₹87 vs previous close ₹88; intraday high/low: ₹89/₹86. The 50 & 200 DMA stand at ₹85.70/₹82.70.

Bal Pharma Performance

  • Today's Low
  • ₹86
  • Today's High
  • ₹89
  • 52 Week Low
  • ₹60
  • 52 Week High
  • ₹99
  • Open Price₹87
  • Previous Close₹88
  • Volume21,713
  • 50 DMA₹85.70
  • 100 DMA₹83.10
  • 200 DMA₹82.70

Bal Pharma Chart

Investment Returns

  • Over 1 Month + 9.95%
  • Over 3 Month + 8.35%
  • Over 6 Month + 15.74%
  • Over 1 Year -4.56%

Smart Investing Starts Here Start SIP with Bal Pharma for Steady Growth!

Invest Now

Bal Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 19.2
  • PEG Ratio
  • 27.1
  • Market Cap Cr
  • 139
  • P/B Ratio
  • 1.7
  • Average True Range
  • 3.7
  • EPS
  • 4.5
  • Dividend Yield
  • 1.4
  • MACD Signal
  • 0.9
  • RSI
  • 49.55
  • MFI
  • 46.25

Latest Stock News Updates

Bal Pharma Ltd - 524824 - Newspaper Publications - Unaudited Financial Results 30Th June 2026 And IEPF Notice

In Continuation of Outcome of Board meeting dated August 12 2026 , Published Unaudited Financial result for the quarter ended 30th June 2026 and IEPF Notice in Financial express and Sanjevani Newspapers on 13th August 2026

Bal Pharma Ltd - 524824 - Financial Result For The Quarter End 30Th June 2026

Enclosed Financial Result for the First quarter ended 30th June 2026 together with Limited Review Report as submitted by Statutory auditor

Bal Pharma Ltd - 524824 - Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday, August 12 2026

Board of directors of the Company met on Wednesday, August 12 2026 inter alia transacted the following business. 1. Considered and approved the unaudited Financial Results (Standalone and Consolidated) of the Company quarter ended on 30th June, 2026 2. Approved the change in designation of Mr. Ravindra Kumar Kothari (DIN: 03418320) from Non-Executive Director to Whole-Time Director, 3. Approved the change in designation of Mr. Virupakshaya Himesh (DIN: 08554422) from Whole-Time Director to Non-Executive Director, with effect from October 1, 2026 4. Approved the proposal to make investment in the proposed Joint Venture entity to be incorporated in the Republic of the Philippines 5 approved the allotment of 10,00,000 (Ten Lakhs) Warrants to Mr. Shailesh Siroya, Promoter of the Company, on preferential basis

Bal Pharma Financials

Bal Pharma Technicals

EMA & SMA

Current Price
₹87.05
-1.19 (-1.35%)
pointer
  • Bearish Moving Average 8
  • Bullish Moving Average 8
  • 20 Day
  • ₹87.80
  • 50 Day
  • ₹85.70
  • 100 Day
  • ₹83.10
  • 200 Day
  • ₹82.70

Resistance and Support

87.42 Pivot Speed
  • R3 91.40
  • R2 90.20
  • R1 88.60
  • S1 85.90
  • S2 84.70
  • S3 83.10

Bal Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-12 Quarterly Results
2026-05-27 Audited Results, Final Dividend & ESOP
2026-02-11 Quarterly Results
2025-11-12 Quarterly Results
2025-08-11 Quarterly Results, ESOP & A.G.M.
Date Purpose Remarks
2025-09-18 FINAL Rs.1.20 per share(12%)Dividend
View Bal Pharma Dividend History Arrow

Bal Pharma Shareholding Pattern

50.86%
48.99%
0.15%
0%

About Bal Pharma

Bal Pharma is engaged in the manufacturing and selling of pharmaceutical products. The Company caters to both domestic and international markets. View More
  • NSE Symbol
  • BALPHARMA
  • BSE Symbol
  • 524824
  • ISIN
  • INE083D01012

Similar Stocks to Bal Pharma

Bal Pharma FAQs

Bal Pharma share price is ₹87 As on 15 August, 2026 | 00:30

The Market Cap of Bal Pharma is ₹138.6 Cr As on 15 August, 2026 | 00:30

The P/E ratio of Bal Pharma is 19.2 As on 15 August, 2026 | 00:30

The PB ratio of Bal Pharma is 1.7 As on 15 August, 2026 | 00:30

The 52 week High & Low of Bal Pharma is ₹98.8/₹60 respectively As on 15 August, 2026 | 00:30

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23